Samuel Mazin is the founder of RefleXion Medical. RefleXion Medical has raised $500M in total funding. Latest round: Series C. Based in Hayward, CA.
Samuel Mazin, Ph.D., is an engineer and the co-founder and CTO of RefleXion Medical, a biotargeting oncology company founded in 2009. He invented the company's biology-guided radiotherapy technology, including the SCINTIX system, which allows machines to see and treat cancer. He received the University of Waterloo's Faculty of Engineering 2021 Alumni Achievement Medal for his contributions.
Full founder directory · Investor directory · Company funding database · Fundraising library